Taiwan FDA registration c8268f89787e675c75d908a72a9abf69
G-Arthur lipoprotein(a) analysis reagent
TW: 克-亞瑟脂蛋白(a)分析試劑
Taiwan·Risk Class 2·KAMIYA BIOMEDICAL COMPANY·Registered Aug 21, 2006 – Aug 21, 2016CancelledRegistration details
- Analysis ID
- c8268f89787e675c75d908a72a9abf69
- Customs Code
- DHA00601728606
Company information
- Manufacturer
- KAMIYA BIOMEDICAL COMPANY
- Manufacturer Country
- United States
- Authorized Representative
- REDOX BIOMEDICINE CO., LTD.
Product details
- Intended Use
- It is used to quantitatively determine the value of lipoprotein (a) in serum.
- Product Type (Level 1)
- C Immunology and microbiology
- Product Type (Level 2)
- C.5580 α-1-脂蛋白免疫試驗系統
- Import Information
- import
Dates and status
- Registration Date
- Aug 21, 2006
- Expiry Date
- Aug 21, 2016
- Cancellation Date
- Jun 26, 2018
Cancellation information
- Status
- Logged out
- Reason
- 許可證已逾有效期
About this record
Access comprehensive regulatory information for G-Arthur lipoprotein(a) analysis reagent in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number c8268f89787e675c75d908a72a9abf69 and manufactured by KAMIYA BIOMEDICAL COMPANY. The authorized representative in Taiwan is REDOX BIOMEDICINE CO., LTD..
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices